Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Recovery From Central Nervous System Acute Demyelination in Children.
Cognition in MS correlates with resting-state oscillatory brain activity: An explorative MEG source-space study.
How embodied is action language? Neurological evidence from motor diseases.
Brain atrophy: an in-vivo measure of disease activity in multiple sclerosis.
Sequencing the immunopathologic heterogeneity in multiple sclerosis.
Humoral responses to herpesviruses are associated with neurodegeneration after a demyelinating event: Results from the Multi-Center SET study.
Evaluation of Cytokines in Multiple Sclerosis Patients Treated with Mesenchymal Stem Cells.
Multiple sclerosis: CCSVI deconstructed and discarded.
Altered Effective Connectivity during a Processing Speed Task in Individuals with Multiple Sclerosis.
Immune regulation of multiple sclerosis by CD8+ T cells.
Two cases of lumbosacral myeloradiculitis with anti-aquaporin-4 antibody.
Susceptibility-weighted imaging in the experimental autoimmune encephalomyelitis model of multiple sclerosis indicates elevated deoxyhemoglobin, iron deposition and demyelination.
Incorporating covariates in skewed functional data models.
Substituted 7-Amino-5-thio-thiazolo[4,5-d]pyrimidines as Potent and Selective Antagonists of the Fractalkine Receptor (CX3CR1).
Investigating the role of the corpus callosum in regulating motor overflow in multiple sclerosis.
DGPPN guideline on anxiety disorders and cognitive dysfunction in the elderly or patients with multiple sclerosis.
Laparoscopic appendectomy in a pediatric patient with type 1 Charcot-Marie-Tooth disease.
Alerted microglia and the sympathetic nervous system: a novel form of microglia in the development of hypertension.
Autoantibodies and Sjogren's Syndrome in Multiple Sclerosis, a Reappraisal.
Vitamin A: yet another player in multiple sclerosis pathogenesis?
Single Dose of Glycoengineered Anti-CD19 Antibody (MEDI551) Disrupts Experimental Autoimmune Encephalomyelitis by Inhibiting Pathogenic Adaptive Immune Responses in the Bone Marrow and Spinal Cord While Preserving Peripheral Regulatory Mechanisms.
Modifiable environmental factors in multiple sclerosis.
Natalizumab and multiple sclerosis.
The Roles of Egr-2 in Autoimmune Diseases.
Growth Hormone and Disease Severity in Early Stage of Multiple Sclerosis.

Pages